User contributions
For
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 18:38, 25 February 2018 (diff | hist) . . (+1,257) . . N NAD depletion (Created page with "Key concepts in ALS ''NAD+ depletion is a common phenomenon in neurodegenerative pathologies. Excitotoxicity occurs in multiple neurologic disorders and NAD+ was shown t...")
- 18:28, 25 February 2018 (diff | hist) . . (+19) . . Key concepts in ALS
- 08:08, 1 February 2018 (diff | hist) . . (+252) . . Information on nutritional supplements people with ALS have been taking
- 12:34, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:27, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:23, 31 January 2018 (diff | hist) . . (+189) . . Information on nutritional supplements people with ALS have been taking
- 12:16, 31 January 2018 (diff | hist) . . (+126) . . Information on nutritional supplements people with ALS have been taking
- 11:55, 31 January 2018 (diff | hist) . . (+64) . . Information on nutritional supplements people with ALS have been taking
- 09:24, 31 January 2018 (diff | hist) . . (+64) . . Information on nutritional supplements people with ALS have been taking
- 07:05, 31 January 2018 (diff | hist) . . (+13) . . Information on nutritional supplements people with ALS have been taking
- 14:38, 28 January 2018 (diff | hist) . . (+1,246) . . Stress granules (current)
- 16:41, 22 January 2018 (diff | hist) . . (+12) . . Uric acid (current)
- 16:32, 22 January 2018 (diff | hist) . . (+1,250) . . N Uric acid (Created page with "Key concepts in ALS ''The pathogenic mechanism of ALS remains unclear. However, increasing evidence has indicated that uric acid (UA) may play a protective role in the pa...")
- 16:27, 22 January 2018 (diff | hist) . . (+37) . . Lab abnormalities (current)
- 11:21, 12 January 2018 (diff | hist) . . (0) . . DMAE (current)
- 11:20, 12 January 2018 (diff | hist) . . (-3,281) . . DMAE
- 08:29, 12 January 2018 (diff | hist) . . (+6) . . Iron metabolism anomalies (current)
- 08:27, 12 January 2018 (diff | hist) . . (+1,842) . . Iron metabolism anomalies
- 06:59, 12 January 2018 (diff | hist) . . (+1,000) . . Autophagy (current)
- 17:50, 13 November 2017 (diff | hist) . . (+1,840) . . MMP-9
- 16:30, 13 November 2017 (diff | hist) . . (+1,747) . . MMP-9
- 16:23, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:20, 13 November 2017 (diff | hist) . . (+1,210) . . MMP-9
- 16:12, 13 November 2017 (diff | hist) . . (+6) . . MMP-9
- 16:10, 13 November 2017 (diff | hist) . . (+1,106) . . MMP-9
- 16:04, 13 November 2017 (diff | hist) . . (+1,267) . . MMP-9
- 15:49, 13 November 2017 (diff | hist) . . (+1,813) . . N MMP-9 (Created page with "Key concepts in ALS == Inhibition == ''Ischemic stroke is a leading cause of disability worldwide. In cerebral ischemia there is an enhanced expression of matrix metallo...")
- 14:55, 13 November 2017 (diff | hist) . . (+24) . . Sulforaphane
- 10:23, 13 November 2017 (diff | hist) . . (+40) . . Plan for an Integral Clinical Trial
- 10:17, 13 November 2017 (diff | hist) . . (+118) . . Plan for an Integral Clinical Trial
- 10:08, 13 November 2017 (diff | hist) . . (+138) . . Plan for an Integral Clinical Trial
- 10:01, 13 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:19, 12 November 2017 (diff | hist) . . (+8) . . Sulforaphane
- 16:15, 12 November 2017 (diff | hist) . . (+20) . . Sulforaphane
- 15:56, 12 November 2017 (diff | hist) . . (0) . . Nrf2 (current)
- 15:55, 12 November 2017 (diff | hist) . . (+6) . . Nrf2
- 15:51, 12 November 2017 (diff | hist) . . (+2,929) . . Nrf2
- 15:49, 12 November 2017 (diff | hist) . . (-2,928) . . Sulforaphane
- 15:47, 12 November 2017 (diff | hist) . . (-1,581) . . Sulforaphane
- 15:43, 12 November 2017 (diff | hist) . . (-1,317) . . Sulforaphane
- 15:42, 12 November 2017 (diff | hist) . . (+4) . . Sulforaphane
- 15:39, 12 November 2017 (diff | hist) . . (+21) . . Key concepts in ALS
- 15:37, 12 November 2017 (diff | hist) . . (0) . . Nrf2
- 15:36, 12 November 2017 (diff | hist) . . (+6) . . Nrf2
- 15:34, 12 November 2017 (diff | hist) . . (+1,386) . . N Nrf2 (Created page with "Key concepts in ALS ''The nuclear factor erythroid 2 related factor 2 (NRF2) is a key regulator of endogenous inducible defense systems in the body. '''Under physiologic...")
- 15:31, 12 November 2017 (diff | hist) . . (+10) . . Key concepts in ALS
- 15:28, 12 November 2017 (diff | hist) . . (+1,318) . . Sulforaphane
- 14:26, 12 November 2017 (diff | hist) . . (+6) . . Sulforaphane
- 13:53, 12 November 2017 (diff | hist) . . (+1,391) . . Sulforaphane
- 21:42, 11 November 2017 (diff | hist) . . (+105) . . Information on nutritional supplements people with ALS have been taking
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)